223

Compound name
Vemurafenib
Alt Name
Vemurafenib
Zelboraf
PLX4032
PLX-4032
Zelboraf
PLX 4032
Compound Image
Vemurafenib.png
SMILES
CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F
MW
489.92
Brutto
C23H18ClF2N3O3S
InChI
InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)
InChI Key
GPXBXXGIAQBQNI-UHFFFAOYSA-N
Approval Jurisdiction
2011 FDA, 2012 EMA
Approved for clinical use
Metastatic Melanoma BRAFV600E
CAS
1029872-54-5
PubChem CID
42611257
Action
B-RAF
Approved Drug List
1
Commercial Vendor
Roche Plexxicon